NVCT
Nuvectis Pharma Inc
22.00$
-0.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | |
| – | 1.01 | 1.52 | 1.47 | – | – | |
| – | -1.01 | -1.51 | -1.47 | – | – | |
| – | 0.75 | 1.04 | 0.99 | 0.75 | 0.83 | |
| 0.00 | 0.26 | 0.47 | 0.48 | 0.40 | 0.43 | |
| 0.00 | 1.01 | 1.52 | 1.47 | 1.16 | 1.26 | |
| 0.00 | -1.01 | -1.52 | -1.47 | -1.16 | -1.26 | |
| 0.00 | 0.00 | 0.01 | – | – | – | |
| 0.00 | -1.01 | -1.51 | -1.43 | -1.11 | -1.21 | |
| 0.00 | 0.00 | -0.02 | 0.00 | -1.11 | – | |
| 0.00 | -1.01 | -1.48 | -1.43 | -1.11 | -1.21 | |
| 0.00 | -1.01 | -1.50 | -1.43 | -1.11 | -1.21 |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.